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http:WHAT THIS PAPER ADDS?
There have been a few papers that have dealt with the issue of palliation of patients diagnosed with an
abdominal aortic aneurysm who are not ﬁt for operative repair, but none that consider this issue alongside the
use of CPEX testing. This topic is one that will be increasingly pertinent in the era of outcome reporting.Objectives: To establish outcome of patients with abdominal aortic aneurysm (AAA) deemed unﬁt for repair.
Design: Retrospective non-randomised study.
Materials and methods: Identiﬁcation of males with >5.5 cm or females with >5.0 cm AAA turned down for
elective repair between 01/01/2006e24/07/2009 from a prospective database. Comorbidities, reasons for non-
intervention, aneurysm size, survival, use of CPEX (cardio-pulmonary exercise) testing and cause of death were
analysed. Although well-established at the time, patients unﬁt for open operation were not considered for
endovascular repair.
Results: Seventy two patients were unsuitable for AAA repair. Aneurysm size ranged from 5.3 cm to 12 cm.
Functional status, comorbidity and patient preference determined decision to palliate. Sixty percent of patients
were alive at study close. Aneurysm rupture was cause of death in 46%. CPEX testing was performed in 54%,
whose mortality was 28%, vs. 54% in the non-CPEX group (P < 0.05).
Median survival of patients with 5.1e6.0 cm AAA was 44 months and 11% died of rupture. Between 6.1 and
7.0 cm median survival was 26 months and 20% died of rupture. However, with >7 cm aneurysms, survival was 6
months and 43% ruptured.
Conclusion: Under half the deaths in our comorbid cohort were due to rupture. However, decision to palliate
may be revisited as risk-beneﬁt ratio changes with aneurysm expansion.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Increasing use of medical imaging and the introduction of
a national screening programme will increase the number
of patients with abdominal aortic aneurysms referred to
vascular surgeons in the UK. Even once at a size that
mandates consideration of repair, there will always be some
patients in whom the risk of aneurysm repair will outweigh
potential survival beneﬁts and those in whom the likelihood
of death from non-aneurysm-related causes is greater than
that from the aneurysm itself. In these cases, life expec-
tancy would not increase despite intervention and the
signiﬁcant mortality and morbidity this entails. This holds
true despite the widespread introduction of minimally
invasive endovascular techniques, which may be favoured
in less ﬁt patients should the anatomy allow, but whose
survival is not improved following intervention.1 Severalrresponding author. Tel.: þ44 07788547537; fax:þ44 01803 654996.
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//dx.doi.org/10.1016/j.ejvs.2012.11.001studies have looked at long-term outcomes in this cohort,
dating back to Szilagyi in the 1970s.2
Patient selection for aneurysm surgery (whether endo-
luminal or open) is based on a number of factors, including
Consultant Vascular Surgeon assessment, cardio-pulmonary
exercise testing (CPEX) and Consultant Anaesthetist review.
The aim was to establish outcome of patients diagnosed
with an abdominal aortic aneurysm (AAA) deemed unﬁt for
surgical intervention and determine whether this selection
process is justiﬁed.MATERIALS AND METHODS
Our unit is a district general hospital serving a resident
population of almost 300,000, with a high proportion of
elderly patients. Selection of patients suitable for aneurysm
repair is based on initial assessment in the outpatient clinic
by a Consultant Vascular Surgeon. This takes into account
comorbidities and functional status, as well as aneurysm
anatomy.
Patients referred with an ASA grade of 4 or above are
excluded based on poor physiological reserve to withstand
operative stress. Some of these patients subsequently
38 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 1 January/2013undergo CPEX testing on patient request. Those with an ASA
grade <4 are then referred to a Consultant Anaesthetist for
further assessment þ/ CPEX testing and depending on
results and patient choice a management decision is made.
Endovascular aneurysm repair (EVAR) techniques have
been used in our unit since 2005 but were performed by
our consultants at a different centre, prior to this. EVAR was
therefore well-established by the study period. However,
following recommendations from the EVAR-2 trial,1
comorbid patients with poor physiological reserve were not
considered for endovascular repair, even if amenable.
In our unit, a prospective database of patients diagnosed
with an AAA referred from outpatient and inpatient sources
is maintained. After 2000, patients from an aneurysm
screening programme were included. Using this database,
males with a >5.5 cm AAA or females with a >5.0 cm AAA
(as deﬁned by the UK small aneurysm trial3), turned down
for elective open aneurysm repair between 01/01/2006e
31/07/2009, were retrospectively identiﬁed. Patients who
initially presented with ruptured, suprarenal or thoracic
aneurysms were excluded.
Aneurysm size was deﬁned as maximum diameter on
ultrasound or, where not available, CT scanning. Aneurysm
size at the time of decision to palliate was conﬁrmed by
reviewing images on our online radiology system. Hospital
records were obtained for all patients and reasons for non-
intervention determined. Cause and time of death were
conﬁrmed by examining death certiﬁcates for those who
died in hospital, by analysing post-mortem reports where
applicable or by consulting the local Public Health Depart-
ment for those who died in the community.
Cardio-pulmonary exercise (CPEX) testing began in our
unit in 2002. Following a diagnosis of a large abdominal
aortic aneurysm, patients are subjected to physical cardio-
pulmonary stress on an exercise bike in order to determine
ﬁtness for surgery. Anaerobic threshold (AT) (the oxygen
consumption level during exercise at which aerobic respi-
ration is substituted by anaerobic mechanisms) and VO2
max (maximum oxygen consumption during exercise or
aerobic capacity) among other parameters are then
measured and the readings obtained used to determine an
objective prediction of likely physiological outcome after
surgical stress. This predicted mortality, combined with
clinical judgement, is used to decide whether a patient
should go forward for surgery and has been demonstrated
to be an accurate predictor of survival.4,5 Use of CPEX
testing for each individual in our study and readings for
anaerobic threshold and/or VO2 max were recorded where
applicable. Values for VO2 max were not available in all
cases as, on introduction of CPEX testing, this parameter
was not universally determined.
Comorbidities, reasons for non-intervention, aneurysm
size, survival, use of CPEX testing and cause of death were
recorded and results analysed. Survival was calculated from
the date of decision to palliate, with end-points being death
or close of study. Patients alive at the end of the study were
censored to the non-rupture group. Survival curves were
plotted using KaplaneMeier analysis, with comparisonusing the log rank test. For categorical data, differences
between groups were compared using the Fisher’s exact
test. Medcalc statistical software (version 12.0.3.0) was
used to perform statistical analysis and a P value <0.05 was
taken to indicate signiﬁcance.RESULTS
A total of 72 patients were palliated during the study period
(55 men and 17 women; ratio 3.2:1). Mean age was 80
years (range 58e93, SD 7.6).
Over a similar period, 122 non-ruptured AAA repairs and
39 ruptured AAA repairs were performed in our unit. 66%
(81 patients) of elective repairs and 5% (2 patients) of
emergency repairs were performed using EVAR techniques.
Mean age in the non-ruptured aneurysm repair group was
71 (range 56e86) and in the ruptured group was 77 (range
60e94). 30-day mortality for non-ruptured and ruptured
aneurysm repairs were 2.46% and 30.76% respectively.
Thus, a total of 194 patients presented in the study period
with non-ruptured AAA of whom 72 (37%) were initially not
offered surgical repair.
Reasons for non-intervention are shown in Table 1. No
patients were turned down on grounds of old age alone,
other factors such as comorbidity and functional status also
being taken into account. Distribution of ASA grade within
our cohort, percentage mortality and percentage rupture
according to ASA grade can be seen in Fig. 1. The majority of
patients with an ASA score of 2 declined operative inter-
vention (5/7 patients).
Overall, 60% (43/72) of patients were alive at end of the
study. Overall whole group median survival was 34 months
with a 5 year survival of 4.2%.
Male mortality was 45% and female 24%. Cause of death
is shown in Table 1. The commonest cause of death was
aneurysm rupture, 41% (n ¼ 12). However, patients dying
of ruptured AAA had a signiﬁcantly longer survival period
(median 11 months, range 0.4e75 months) compared to
non-aneurysm related deaths (5 months, range 2.6e26
months), P ¼ 0.04 (Fig. 2). We were unable to determine
cause of death in 1 patient, as he died abroad.
Only 7 (24%) of our patient group underwent post-mor-
tem examination and of these, 4 died of a ruptured aneu-
rysm. Cause of death was determined from death
certiﬁcates in a further 13 patients. In the remaining cases,
the local Public Health Department was consulted.
Ten patients refused surgery (mean age 80 vs. 81 for all
other patients). Of this group, 4 died before the end of the
study, 3 of these due to aneurysm rupture. The fourth died
from a myocardial infarction (Fig. 3: Summary of outcomes
for patient cohort). Survival in the patient refusal group was
greater than that in the group of patients turned down on
clinical grounds, (although statistical signiﬁcance was not
reached); median survival in the patient refusal group being
46 months compared with 26 months for those turned
down for repair (P ¼ 0.08).
Patients were stratiﬁed into 3 groups based on aneurysm
size at the time of a decision to palliate in order to assess
Table 1. Reasons for non-intervention.
Reason for
non-intervention
Number of
patients
% Died Cause of
death
Patient refused 10 40% (4 patients) 3 Ruptured AAA
Cardiovascular disease 7 86% (6 patients) 2 Ruptured AAA
2 MI
1 Cardiorespiratory arrest
1 Renal failure
Chronic obstructive pulmonary disease 15 33% (5 patients) 3 Ruptured AAA
1 Sepsis
1 Unable to obtain
Carcinoma 7 43% (3 patients) 3 Carcinoma
Multifactorial:
>2 of CVE, IHD, Cardiac failure, Carcinoma,
COPD, poor CPEX result, DM, Chronic renal
failure, Dementia
27 30% (8 patients) 2 Ruptured AAA
2 Sepsis
1 CVA
1 Renal failure
1 Respiratory arrest
1 Dementia
Poor exercise tolerance 5 40% (2 patients) 2 Ruptured AAA
Dialysis-dependent chronic renal failure 1 (aged 80) 100% (1 patient) 1 MI
C.E. Western et al. 39the effect of AAA size on survival (Table 2 and Fig. 4). As
would be expected, as aneurysm size increased so survival
decreased signiﬁcantly.
Four patients underwent AAA surgery after an initial
decision not to proceed. Two patients underwent elective
open aneurysm repair: 1 at another unit, following assess-
ment by a different Vascular team (post-operative survival
at the close of the study ¼ 17 months) and 1 as the
aneurysm size increased sufﬁciently to warrant the risks of
surgery. Unfortunately, this patient died post-operatively.
Two patients in our cohort, presenting with rupture,
underwent emergency open aneurysm repair following
further discussion with patient and family regarding deci-
sion to palliate. One of whom survived (post-operative
survival at the close of the study ¼ 3.5 months) and one of
whom died following surgery at another centre.ASA 1 ASA
Died non-rupture 0 3
Died rupture 0 2
Alive 0 3
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Figure 1. Graph to show patient outcome and causeOn assessment of anatomical suitability for endovascular
aneurysm repair, 58% (42 patients) were seen to be
amenable to EVAR. Of these, 6/42 (14%) refused interven-
tion and of those left, 3% (1 patient) were ASA-2, 53% (19
patients) ASA-3 and 44% (16 patients) ASA-4. In keeping
with recommendations from the EVAR-2 trial,1 if patients
were deemed unﬁt for open aneurysm repair, they were not
put forward for endograft repair.
Forty patients (56%) underwent CPEX testing. Mortality
in this group was 28% compared with 55% in the non-CPEX
group (P < 0.05) (median survival 46 vs. 21 months). Values
for anaerobic threshold ranged from 4 to 14 mlO2/kg/min
but 6 patients were unable to pedal adequately to reach
anaerobic threshold. VO2 max varied from 5.6 ml/kg/min to
15.6 ml/kg/min but was not recorded for 11 patients,
including 2 patients who were unable to perform the test 2 ASA 3 ASA 4
7 3
4 9
30 10
of death when stratiﬁed according to ASA grade.
Figure 2. Survival when stratiﬁed according to cause of death.
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days of our CPEX programme.DISCUSSION
The number of patients palliated by each surgical unit will
depend on patient ﬁtness and surgical thresholds for
intervention. Over the study period, 37% of those pre-
senting to our unit with non-ruptured AAA were initially
conservatively treated.
This rate is slightly higher than that seen on literature
review, quoted ﬁgures ranging from 18% (Heikkinen et al.6)
to 32% (Szilagyi et al.2). However, half of the papers
reviewed did not state volume of elective work and so
palliation rates were not calculable.
The obvious question arises: are we being too exclusive
in our selection policy for operative repair? Our electiveFigure 3. Flow-chart demonstratingmortality for AAA repair (open and EVAR) being 2.5%,
compared with 4.2% from the 2009 National Vascular
Database.7 It is likely that this difference is largely attrib-
utable to our patient demographic, which consists of a high
proportion of elderly and consequent high endemic co-
morbidity, precluding aneurysm repair.
Our end-of-study survival (60%) is equivalent to that of
the non-operated group in the EVAR-2 trial1 and our
rupture rate of 41% is similar to that quoted by Szilagyi
(45%),2 Lederle8(40%) and Jones9 (38%). Mortality rates in
the literature ranging from 29%10 to 49%11 (See Table 3).
Unsurprisingly, in keeping with the literature,9,11 median
survival declined and proportion of patients dying from
rupture increased with increasing aneurysm size.
Darling10 reviewed outcomes following emergency
surgery in 60 consecutive patients presenting in the 1960s
with aneurysm rupture who had been turned down foroutcomes of our patient cohort.
Table 2. Features of non-operated AAA when stratiﬁed according
to size.
Aneurysm size 5.1e6.0 cm 6.1e7.0 cm >7.0 cm
Number of patients 45 20 7
Median age (range,
standard deviation)
79(58e93,
SD 7.9)
83(67e91,
SD 5.9)
84(75e94,
SD 6.7)
Alive 29 12 2
Dead e rupture (%) 5 (11%) 4 (20%) 3 (43%)
Dead e non-rupture 11 4 2
Median survival:
months (range)
44 (1.5e72) 26 (0.5e75) 6 (0.4e17)
C.E. Western et al. 41elective repair due to age, comorbidities or patient refusal.
Of this series 13% died intra-operatively from shock, 8%
died in the ﬁrst 5 days following surgery and a further 18%
died between day 6 and 3 months. He argued that as 60%
of this group who underwent emergency aneurysm repair
survived to leave hospital, but elective mortality in this
centre was less than 3%, “all aneurysms should be treated
pre-rupture, independent of comorbidities”.
So, could we have improved survival in our study group by
operating on all cases? 59% of deaths were due to causes
other than rupture and 30-day mortality in the 4 patients
who, subsequent to initial assessment, underwent repair was
50% indicating that an aggressive surgical approach in this
cohort carries a high mortality and suggests that in the
majority of cases, outcomeswould be unchanged. However, it
is not just quantity but quality of life whichmust be taken into
account. A longer post-operative inpatient stay, with associ-
ated complications and the complex issues surrounding
health care economics also need to be considered if long-term
survival is not greatly improved in this cohort.Figure 4. Survival when stratiﬁedMedian survival in those who died from aneurysm
rupture was signiﬁcantly greater than that for those who
died of other medical causes (11 months vs. 5 months,
P ¼ 0.04). This reﬂects severity of comorbity and demon-
strates the futility of operative intervention in the non-
rupture cohort.
Cardio-pulmonary exercise testing is an accepted pre-
operative investigation in elective major surgical cases as it
offers a standardised, reproducible measure of physiological
ﬁtness. Armed with this information, clinicians can make an
objective judgement regarding surgical suitability and
patients themselves have a measure of their ﬁtness and so
how they may fare intraoperatively. The sensitivity of CPEX
to predict survival following surgical intervention is well
illustrated. A study by Older et al., looking at outcomes in
the elderly following major intra-abdominal surgery,
demonstrated a mortality of 18% in the group whose pre-op
anaerobic threshold was <11, whereas in those with an
anaerobic threshold >11 mortality was 0.8% (P < 0.001).14
56% of our cohort (40 patients) underwent CPEX
assessment and on testing, only 4 of 40 patients achieved
an anaerobic threshold greater than or equal to 11, the
level generally taken as the cut off for cardiopulmonary
capacity to withstand major surgery.14 Of these 4 patients, 1
declined surgery, the other 3 had small abdominal aneu-
rysms (<6 cm), 1 with a co-existent thoracic aneurysm.
Within our series, mortality in the CPEX group was
signiﬁcantly lower than that in those who did not undergo
testing (P < 0.05). This reﬂects the fact that CPEX testing
was, in the early stages, only employed in those borderline
cases in which there was uncertainty (69% of patients of
ASA grade 3 were tested, compared with 32% of ASA gradeaccording to aneurysm size.
Table 3. Comparison of studies in the literature assessing outcome of unﬁt patients with AAA.
Study authors Date Size of
cohort
% Mortality Rupture deaths as a %
of all-cause deaths
Rupture deaths as a %
of total cohort size
Szilagyi et al.2 1944e1965 223 78% 45% 35%
RC Darling10 1952e1968 282 Autopsy series 29% 29%
Conway et al.11 1989e1999 106 72% 49% 35%
Jones et al.9 1985e1994 57 88% 38% 33%
Brown et al.12 1976e2001 400 32% 31% 10%
Heikkinen et al.6 1990e1998 23 87% 25% 22%
Lederle et al.8 1995e2000 198 57% 40% 23%
Tambyraja et al.13 1995e1999 125 61% 36% 22%
Western et al. 2006e2009 72 40% 41% 17%
42 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 1 January/20134), there being little clinical doubt in those not undergoing
assessment about their inability to survive operative stress.
Also of note, 80% (4 out of 5) of patients with an ASA
grade of 2 who did not undergo CPEX testing, declined
operative repair.
There were 10 patients in our study who declined
surgery. Median survival in this group was markedly longer
than that in the group turned down for operation and this is
unsurprising given that the majority of patients who refused
operation were suitable candidates for surgery had they
been in agreement with clinical recommendations.
Patients not suitable for operative AAA repair should of
course be medically optimised to reduce both cardiovas-
cular and rupture risk. Statin use has been shown to reduce
both rupture risk and expansion rate,15e17 as have ACE
inhibitors18 and there is an inverse correlation between
cigarette smoking and aneurysm growth.19 These measures
are part of the standardised regime for optimisation of
cardiovascular risk factors undertaken in all vascular
patients.
Given the higher frequency of rupture in larger aneu-
rysms, a more aggressive surgical approach is often taken
and, in comorbid patients, operative intervention may be
delayed until aneurysm size increases adequately to
warrant operative risk. The balance between surgical risk
and beneﬁt is dynamic and may change as an AAA enlarges.
The issue of palliation may therefore need to be revisited
and this cohort may beneﬁt therefore from continued
aneurysm surveillance.LIMITATIONS OF OUR STUDY
Cause of death in most cases was deﬁned by death certif-
icate and this is therefore a potential source of inaccuracy
as deaths attributed to rupture, where no premortem CT
scan or post-mortem were performed, cannot be veriﬁed.
Another potential limitation arises from the radiological
assessment of aneurysm size. Aneurysm size was deﬁned in
our unit as maximum diameter measurable, independent of
orientation, rather than maximum antero-posterior diam-
eter, which is thought to be more reproducible20 and
a better predictor of rupture risk.21,22 In some individuals,
CT alone was performed or was the most up to date
imaging; a modality which often over-estimates AAA size
when compared with ultrasound.23,24 However, theadjustment of aneurysm diameter by a few millimetres at
most is unlikely to have inﬂuenced decision making in most
cases.
CONCLUSIONS
Even in the era of minimally invasive techniques, through
greater understanding of the natural history of AAA and
patient-related factors, risk stratiﬁcation can be used to
select those likely to beneﬁt from prolonged life expectancy
as a result of intervention. CPEX testing is used in our centre
to assist decision making and by employing such a stand-
ardised multidisciplinary approach to patient selection
nationwide through anaesthetic, surgical and radiological
input we may reduce operative mortality. The potential to
improve operative survival by pre-operative medical opti-
misation and physical conditioning is an area for future
study.ETHICS
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